Fintel · Nov 2, 2026
MD
NYSE · MD
Pediatrix Medical Group, Inc.
Healthcare · Medical - Care Facilities
$32.80
Up+$2.20 (+7.19%)
Updated Nov 5, 2026, 5:47 AM
SID Score
7.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.9B
- P/E ratio
- 11.54
- Dividend yield
- 0.00%
- 52-week range
- $19.06 – $31.07
- Volume
- 1.19M
- Avg. volume
- 931.29K
Price performance · MD
MD price history
1M range · 0 trading sessions · Daily adjusted prices
MD does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest MD news
The latest Smart Investors Daily articles mentioning MD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
MD research
Overview
Company profile and research snapshot.
Company profile
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $23.50
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Truist Securities | Hold | — |
| Aug 19, 2026 | Jefferies | Hold | — |
| Aug 6, 2026 | UBS | Neutral | — |
| Jul 14, 2026 | Truist Securities | Hold | — |
| May 12, 2026 | UBS | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 31, 2026
Pediatrix Medical Group (MD) Q3 Results Leave Margin Pressure In Focus
Pediatrix Medical Group walked into its Q3 2026 report with the stock quietly grinding higher over the past month, then picked up another 2.2% in the first trading session after the release. On the surface that looks like a modest cheer, not a frenzy. Yet the earnings story is bigger than a one day bump, with basic earnings per share at about $0.59 and adjusted EBITDA at $85.5 million, and investors weighing whether this move finally reflects growing confidence in a still pressured margin...
Benzinga · Oct 30, 2026
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.
Yahoo · Oct 30, 2026
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
Pediatrix Medical Group (NYSE:MD) reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery. The company narrowed its full-year adjusted EBITDA outlook to a range of $290 million to $300 millio
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
